Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma

Journal of Cosmetic Dermatology

Volumn 10, Issue 3, 2011, Pages 189-196

  Gold, Michael H ^a   Biron, Julie ^b  

^a GOLD SKIN CARE CENTER   (United States)

^b Tennessee Clinical Research Center   (United States)

Author keywords

Antiaging; Melanin; Photoaging; Pigmentation; Skin lightening; Tyrosinase

Indexed keywords

DERMATOLOGICAL AGENT; DISODIUM GLYCEROPHOSPHATE; HYDROQUINONE; LEUCINE; MELAPLEX; PHENYLETHYL RESORCINOL; SKIN BRIGHTENING AGENT; SUNSCREEN; UNCLASSIFIED DRUG; UNDECYLENOYL PHENYLALANINE;

ADULT; ARTICLE; BURNING SENSATION; CHLOASMA; CLINICAL ARTICLE; CREAM; DEPIGMENTATION; DISEASE SEVERITY; DRUG TOLERABILITY; EMULSION; ERYTHEMA; FEMALE; HUMAN; LENTIGO; PRIORITY JOURNAL; PRURITUS; SKIN ATROPHY; SKIN EXFOLIATION; SKIN PIGMENTATION;

ADULT; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FEMALE; GLYCEROPHOSPHATES; HUMANS; LEUCINE; LIPOPEPTIDES; MELANOCYTE-STIMULATING HORMONES; MELANOSIS; MIDDLE AGED; PHENYLALANINE; RESORCINOLS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80052473330     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2011.00573.x     Document Type: Article

References (23)

1. Pankovich JM, Jimbow K. Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues. Biochem J 1991; 280: 721-5.
2. Potterf SB, Muller J, Bernardini I et al. Characterization of a melanosomal transport system in murine melanocytes mediating entry of the melanogenic substrate tyrosine. J Biol Chem 1996; 271: 4002-8.
3. Schallreuter KU, Wood JM. The importance of L-phenylalanine transport and its autocrine turnover to L-tyrosine for melanogenesis in human epidermal melanocytes. Biochem Biophys Res Commun 1999; 262: 423-8.
4. Van Den Bossche K, Naeyaert JM, Lambert J. The quest for the mechanism of melanin transfer. Traffic 2006; 7: 769-78.
5. Joshi PG, Nair N, Begum G et al. Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. Pigment Cell Res 2007; 20: 380-4.
6. Rouzaud F, Kadekaro AL, Abdel-Malek ZA et al. MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res 2005; 571: 133-52.
7. Solano F, Briganti S, Picardo M et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 2006; 19: 550-71.
8. Ando H, Kondoh H, Ichihashi M et al. Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. J Invest Dermatol 2007; 127: 751-61.
9. Department of Health and Human Services - Food and Drug Administration. Skin bleaching drug products for over-the-counter human use; proposed rule. Federal Register 2006; 71: 51146-55.
10. SCCP (Scientific Committee on Consumer Products). Opinion on Kojic Acid, 30 September 2008. Available at: accessed September 20, 2010.
11. Berson DS, Cohen JL, Rendon MI et al. Clinical role and application of superficial chemical peels in today's practice. J Drugs Dermatol 2009; 8: 803-11.
12. McDaniel DH, Wu J. Efficacy of a natural-based bleaching cream versus hydroquinone 4% bleaching gel in the treatment of hyperpigmentation. Cosmet Dermatol 2008; 21: 596-602.
13. Kornhauser A, Wei RR, Yamaguchi Y et al. The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin. J Dermatol Sci 2009; 55: 10-7.
14. Kaidbey K, Sutherland B, Bennett P et al. Topical glycolic acid enhances photodamage by ultraviolet light. Photodermatol Photoimmunol Photomed 2003; 19: 21-7.
15. Tsai TF, Bowman PH, Jee SH et al. Effects of glycolic acid on light-induced skin pigmentation in Asian and caucasian subjects. J Am Acad Dermatol 2000; 43: 238-43.
16. Kimbrough-Green CK, Griffiths CE, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-33.
17. Pandya AG, Hynan LS, Bhore R et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 2011; 64: 78-83.
18. Ishikawa M, Kawase I, Ishii F. Combination of amino acids reduces pigmentation in B16F0 melanoma cells. Biol Pharm Bull 2007; 30: 677-81.
19. Vielhaber G, Schmaus G, Jacobs K et al. 4-(1-Phenylethyl)1, 3-benzenediol: a new, highly efficient lightening agent. IFSCC Magazine 2006; 9: 2-9.
20. Stoltz C, Garcia C. Use of a compound inactivating the kinase A protein in a composition containing a cosmetically acceptable medium in order to lighten the skin. United States Patent Application 2005/0118119.
21. Levitt J. The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register. J Am Acad Dermatol 2007; 57: 854-72.
22. Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996; 22: 443-7.
23. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 1999; 25: 282-4.